ORTHOCELL LIMITED - Announcements

1.63%

$1.25

Market Cap $301.1M

Technology Scientific & Technical Instruments

Orthocell Limited is an Australia-based regenerative medicine company. The Company is... Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes Striate+, Remplir, and OrthoACI. Striate+ is a sterile, resorbable collagen membrane used for guided bone and tissue regeneration in dental applications. Remplir is a collagen scaffold used in peripheral nerve repair. OrthoACI or autologous chondrocyte implantation is used for the treatment of articular cartilage defects in the knee and ankle. OrthoACI uses the patient’s own healthy cartilage cells called chondrocytes to assist the regeneration of damaged cartilage. The Company is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. LATEST: Race Oncology Accelerates Game-Changing Cancer Drug.

Announcements

Filter Results

All Price Sensitive Only

OCC	Appendix 4C - quarterly-OCC.AX	PRICE SENSITIVE	29/04/16	167.82KB	Share
OCC	Cell Factory Concept Further Validated in Leading Journal-OCC.AX	PRICE SENSITIVE	20/04/16	386.2KB	Share
OCC	Investor Presentation 28th Annual ROTH Conference		15/03/16	1.2MB	Share
OCC	Change of Director's Interest Notice SW		04/03/16	23.03KB	Share
OCC	Change of Director's Interest Notice PA		04/03/16	23.23KB	Share
OCC	Change of Director's Interest Notice LL		04/03/16	22.54KB	Share
OCC	Change of Director's Interest Notice QZ		04/03/16	20.77KB	Share
OCC	Professor Rocky Tuan Appointed to Orthocell Advisory Board		04/03/16	475.9KB	Share
OCC	Appendix 3B		26/02/16	619.85KB	Share
OCC	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/16	653.19KB	Share
OCC	Appendix 4C - quarterly	PRICE SENSITIVE	29/01/16	169.14KB	Share
OCC	Results of Meeting		27/01/16	426.42KB	Share
OCC	Tendon Data Presented at International Hip Conference	PRICE SENSITIVE	21/01/16	464.57KB	Share
OCC	Orthocells Cell Factory Granted Patent in US	PRICE SENSITIVE	05/01/16	226.46KB	Share
OCC	Notice of General Meeting/Proxy Form		22/12/15	654.44KB	Share
OCC	Approval for Human Tendon Study Using Celgro Received	PRICE SENSITIVE	16/12/15	57.48KB	Share
OCC	Orthocell Key Scaffold Patent Granted in Canada	PRICE SENSITIVE	09/12/15	312.68KB	Share
OCC	Investor Presentation		30/11/15	1.78MB	Share
OCC	Results of Meeting		27/11/15	21.59KB	Share
OCC	Change in substantial holding SRV		25/11/15	100.1KB	Share
OCC	Change in substantial holding MC		25/11/15	108.97KB	Share
OCC	Orthocell Key Patents Granted for Celgro and Ortho-ATI	PRICE SENSITIVE	25/11/15	222.53KB	Share
OCC	Becoming a substantial holder		23/11/15	318.78KB	Share
OCC	Institutional Component of US Led Placement Completed		19/11/15	229.7KB	Share
OCC	Appendix 3B		19/11/15	613.76KB	Share
OCC	First Singapore Patient Receives Cartilage Therapy Ortho-ACI	PRICE SENSITIVE	18/11/15	227.69KB	Share
OCC	Orthocell to raise up to $4.4 million in US Led Placement	PRICE SENSITIVE	17/11/15	338.05KB	Share
OCC	Trading Halt	PRICE SENSITIVE	16/11/15	362.86KB	Share
OCC	Positive Initial Results Using Celgro in Dental Study	PRICE SENSITIVE	10/11/15	254.18KB	Share
OCC	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/15	569.81KB	Share
OCC	Ortho-ATI Tendon Treatment Positive in Workers Comp Study	PRICE SENSITIVE	28/10/15	315.41KB	Share
OCC	Appendix 4G		27/10/15	208.93KB	Share
OCC	Annual Report to shareholders		27/10/15	3.68MB	Share
OCC	Notice of Annual General Meeting/Proxy Form		27/10/15	661.47KB	Share
OCC	Tendon Regeneration Data Presented at South Africa Meeting	PRICE SENSITIVE	22/10/15	301.78KB	Share
OCC	Technology and Data Presentations at key Ortho Conferences	PRICE SENSITIVE	15/10/15	221.6KB	Share
OCC	Orthocell Presents at Stem Cell Meeting on the Mesa		08/10/15	1.54MB	Share
OCC	Investor Presentation		23/09/15	1.89MB	Share
OCC	Full Year Statutory Accounts		18/09/15	743.33KB	Share
OCC	Further Details to Cell Factory Announcement and Update	PRICE SENSITIVE	16/09/15	307.46KB	Share
OCC	Orthocells Cell Factory validated for bone regeneration	PRICE SENSITIVE	15/09/15	304.8KB	Share
OCC	Preliminary Final Report	PRICE SENSITIVE	28/08/15	132.72KB	Share
OCC	Orthocell Holds Inaugural User Group Meeting		11/08/15	222.87KB	Share
OCC	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/15	541.86KB	Share
OCC	Response to ASX Aware Query	PRICE SENSITIVE	27/07/15	354.44KB	Share
OCC	Release of Securities from Escrow		17/07/15	170.92KB	Share
OCC	Pipeline Cartilage Product Validated in Leading Publication	PRICE SENSITIVE	16/07/15	300.78KB	Share
OCC	Grant for World First Laboratory Grown Tendon Received	PRICE SENSITIVE	09/07/15	221.64KB	Share
OCC	Response to ASX Price Query	PRICE SENSITIVE	06/07/15	277.74KB	Share
OCC	Orthocell Receives R&D Tax Incentive Cash Refund	PRICE SENSITIVE	28/05/15	179.26KB	Share
OCC	Orthocell presents at London Regenerative Medicine Congress		25/05/15	299.56KB	Share
OCC	Ortho-ATI Data Presented at Key International Conference	PRICE SENSITIVE	12/05/15	222.45KB	Share
OCC	Release of Shares from Escrow		12/05/15	170.82KB	Share
OCC	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/15	213.05KB	Share
OCC	Prestigious Journal Publishes Ortho-ATI Study Findings		30/04/15	213.21KB	Share
OCC	Investor Presentation		17/03/15	2.08MB	Share
OCC	Orthocell Receives Approval for Celgro Dental Study	PRICE SENSITIVE	09/03/15	306.39KB	Share
OCC	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/15	682.59KB	Share
OCC	First Patients in Hong Kong Treated With Ortho-ATI Therapy	PRICE SENSITIVE	09/02/15	222.87KB	Share
OCC	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/15	712.2KB	Share
OCC	US Patent Received for CELGRO	PRICE SENSITIVE	29/01/15	226.64KB	Share
OCC	Chinese Patent for Celgro Technology Granted	PRICE SENSITIVE	15/01/15	231.24KB	Share
OCC	Orthocell Signs Agreement with BONESUPPORT	PRICE SENSITIVE	08/12/14	257.16KB	Share
OCC	Change of Director's Interest Notice x 5		25/11/14	101.23KB	Share
OCC	Appendix 3B		24/11/14	556.33KB	Share
OCC	Results of Meeting		24/11/14	69.22KB	Share
OCC	2014 AGM Managing Directors Presentation		24/11/14	2.58MB	Share
OCC	First Human Tendons Grown in Laboratory	PRICE SENSITIVE	06/11/14	108.96KB	Share
OCC	Appendix 4C - quarterly cashflow report	PRICE SENSITIVE	31/10/14	596.9KB	Share
OCC	Annual Report to shareholders		24/10/14	2.95MB	Share
OCC	Notice of Annual General Meeting/Proxy Form		22/10/14	816.39KB	Share
OCC	Ortho ATI to be Highlighted at Leading Conferences		16/10/14	222.79KB	Share
OCC	Full Year Statutory Accounts		22/09/14	1.29MB	Share
OCC	Patent Received Use of Ortho-ATI for Rotator Cuff Injuries	PRICE SENSITIVE	16/09/14	227.44KB	Share
OCC	Change of Director's Interest Notice LL		16/09/14	218.04KB	Share
OCC	Investor Presentation		02/09/14	2.74MB	Share
OCC	Preliminary Final Report	PRICE SENSITIVE	29/08/14	268.42KB	Share
OCC	Ortho-ATI Study Proves Long Term Effectiveness	PRICE SENSITIVE	25/08/14	216.59KB	Share
OCC	Becoming a substantial holder MZ		22/08/14	1014.38KB	Share
OCC	Becoming a substantial holder XU		22/08/14	339.32KB	Share
OCC	Change of Director's Interest Notice SW		19/08/14	217.88KB	Share
OCC	Becoming a substantial holder		14/08/14	140.37KB	Share
OCC	Change of Director's Interest Notice SW		13/08/14	217.84KB	Share
OCC	Orthocell generates first royalties from China	PRICE SENSITIVE	12/08/14	214.84KB	Share
OCC	Investor Presentation		12/08/14	2.65MB	Share
OCC	Becoming a substantial holder MC		12/08/14	1.1MB	Share
OCC	Becoming a substantial holder QZ		12/08/14	1.37MB	Share
OCC	Becoming a substantial holder from SRV		12/08/14	28.46KB	Share
OCC	*Initial Director's Interest Notice 5**		12/08/14	261.06KB	Share
OCC	Becoming a substantial holder PA		12/08/14	157.76KB	Share
OCC	Schedule of Restricted Securities		07/08/14	28.53KB	Share
OCC	Statement confirming issue of unquoted options		07/08/14	39.19KB	Share
OCC	Securities Trading Policy		07/08/14	186.52KB	Share
OCC	Corporate Governance Statement		07/08/14	136.88KB	Share
OCC	Reviewed account for half year ending 31 December 2013		07/08/14	4.1MB	Share
OCC	Audited account for year ending 30 June 2013		07/08/14	1.31MB	Share
OCC	Audited account for year ending 30 June 2012		07/08/14	743.08KB	Share
OCC	Audited account for year ending 30 June 2011		07/08/14	6.09MB	Share
OCC	Constitution		07/08/14	484.89KB	Share
OCC	Appendix 1A Information Form & Checklist		07/08/14	1.31MB	Share

OCC Appendix 4C - quarterly-OCC.AX
29/04/16	PRICE SENSITIVE	167.82KB	Share
OCC Cell Factory Concept Further Validated in Leading Journal-OCC.AX
20/04/16	PRICE SENSITIVE	386.2KB	Share
OCC Investor Presentation 28th Annual ROTH Conference
15/03/16		1.2MB	Share
OCC Change of Director's Interest Notice SW
04/03/16		23.03KB	Share
OCC Change of Director's Interest Notice PA
04/03/16		23.23KB	Share
OCC Change of Director's Interest Notice LL
04/03/16		22.54KB	Share
OCC Change of Director's Interest Notice QZ
04/03/16		20.77KB	Share
OCC Professor Rocky Tuan Appointed to Orthocell Advisory Board
04/03/16		475.9KB	Share
OCC Appendix 3B
26/02/16		619.85KB	Share
OCC Half Yearly Report and Accounts
26/02/16	PRICE SENSITIVE	653.19KB	Share
OCC Appendix 4C - quarterly
29/01/16	PRICE SENSITIVE	169.14KB	Share
OCC Results of Meeting
27/01/16		426.42KB	Share
OCC Tendon Data Presented at International Hip Conference
21/01/16	PRICE SENSITIVE	464.57KB	Share
OCC Orthocells Cell Factory Granted Patent in US
05/01/16	PRICE SENSITIVE	226.46KB	Share
OCC Notice of General Meeting/Proxy Form
22/12/15		654.44KB	Share
OCC Approval for Human Tendon Study Using Celgro Received
16/12/15	PRICE SENSITIVE	57.48KB	Share
OCC Orthocell Key Scaffold Patent Granted in Canada
09/12/15	PRICE SENSITIVE	312.68KB	Share
OCC Investor Presentation
30/11/15		1.78MB	Share
OCC Results of Meeting
27/11/15		21.59KB	Share
OCC Change in substantial holding SRV
25/11/15		100.1KB	Share
OCC Change in substantial holding MC
25/11/15		108.97KB	Share
OCC Orthocell Key Patents Granted for Celgro and Ortho-ATI
25/11/15	PRICE SENSITIVE	222.53KB	Share
OCC Becoming a substantial holder
23/11/15		318.78KB	Share
OCC Institutional Component of US Led Placement Completed
19/11/15		229.7KB	Share
OCC Appendix 3B
19/11/15		613.76KB	Share
OCC First Singapore Patient Receives Cartilage Therapy Ortho-ACI
18/11/15	PRICE SENSITIVE	227.69KB	Share
OCC Orthocell to raise up to $4.4 million in US Led Placement
17/11/15	PRICE SENSITIVE	338.05KB	Share
OCC Trading Halt
16/11/15	PRICE SENSITIVE	362.86KB	Share
OCC Positive Initial Results Using Celgro in Dental Study
10/11/15	PRICE SENSITIVE	254.18KB	Share
OCC Appendix 4C - quarterly
30/10/15	PRICE SENSITIVE	569.81KB	Share
OCC Ortho-ATI Tendon Treatment Positive in Workers Comp Study
28/10/15	PRICE SENSITIVE	315.41KB	Share
OCC Appendix 4G
27/10/15		208.93KB	Share
OCC Annual Report to shareholders
27/10/15		3.68MB	Share
OCC Notice of Annual General Meeting/Proxy Form
27/10/15		661.47KB	Share
OCC Tendon Regeneration Data Presented at South Africa Meeting
22/10/15	PRICE SENSITIVE	301.78KB	Share
OCC Technology and Data Presentations at key Ortho Conferences
15/10/15	PRICE SENSITIVE	221.6KB	Share
OCC Orthocell Presents at Stem Cell Meeting on the Mesa
08/10/15		1.54MB	Share
OCC Investor Presentation
23/09/15		1.89MB	Share
OCC Full Year Statutory Accounts
18/09/15		743.33KB	Share
OCC Further Details to Cell Factory Announcement and Update
16/09/15	PRICE SENSITIVE	307.46KB	Share
OCC Orthocells Cell Factory validated for bone regeneration
15/09/15	PRICE SENSITIVE	304.8KB	Share
OCC Preliminary Final Report
28/08/15	PRICE SENSITIVE	132.72KB	Share
OCC Orthocell Holds Inaugural User Group Meeting
11/08/15		222.87KB	Share
OCC Appendix 4C - quarterly
31/07/15	PRICE SENSITIVE	541.86KB	Share
OCC Response to ASX Aware Query
27/07/15	PRICE SENSITIVE	354.44KB	Share
OCC Release of Securities from Escrow
17/07/15		170.92KB	Share
OCC Pipeline Cartilage Product Validated in Leading Publication
16/07/15	PRICE SENSITIVE	300.78KB	Share
OCC Grant for World First Laboratory Grown Tendon Received
09/07/15	PRICE SENSITIVE	221.64KB	Share
OCC Response to ASX Price Query
06/07/15	PRICE SENSITIVE	277.74KB	Share
OCC Orthocell Receives R&D Tax Incentive Cash Refund
28/05/15	PRICE SENSITIVE	179.26KB	Share
OCC Orthocell presents at London Regenerative Medicine Congress
25/05/15		299.56KB	Share
OCC Ortho-ATI Data Presented at Key International Conference
12/05/15	PRICE SENSITIVE	222.45KB	Share
OCC Release of Shares from Escrow
12/05/15		170.82KB	Share
OCC Appendix 4C - quarterly
30/04/15	PRICE SENSITIVE	213.05KB	Share
OCC Prestigious Journal Publishes Ortho-ATI Study Findings
30/04/15		213.21KB	Share
OCC Investor Presentation
17/03/15		2.08MB	Share
OCC Orthocell Receives Approval for Celgro Dental Study
09/03/15	PRICE SENSITIVE	306.39KB	Share
OCC Half Yearly Report and Accounts
26/02/15	PRICE SENSITIVE	682.59KB	Share
OCC First Patients in Hong Kong Treated With Ortho-ATI Therapy
09/02/15	PRICE SENSITIVE	222.87KB	Share
OCC Appendix 4C - quarterly
30/01/15	PRICE SENSITIVE	712.2KB	Share
OCC US Patent Received for CELGRO
29/01/15	PRICE SENSITIVE	226.64KB	Share
OCC Chinese Patent for Celgro Technology Granted
15/01/15	PRICE SENSITIVE	231.24KB	Share
OCC Orthocell Signs Agreement with BONESUPPORT
08/12/14	PRICE SENSITIVE	257.16KB	Share
OCC Change of Director's Interest Notice x 5
25/11/14		101.23KB	Share
OCC Appendix 3B
24/11/14		556.33KB	Share
OCC Results of Meeting
24/11/14		69.22KB	Share
OCC 2014 AGM Managing Directors Presentation
24/11/14		2.58MB	Share
OCC First Human Tendons Grown in Laboratory
06/11/14	PRICE SENSITIVE	108.96KB	Share
OCC Appendix 4C - quarterly cashflow report
31/10/14	PRICE SENSITIVE	596.9KB	Share
OCC Annual Report to shareholders
24/10/14		2.95MB	Share
OCC Notice of Annual General Meeting/Proxy Form
22/10/14		816.39KB	Share
OCC Ortho ATI to be Highlighted at Leading Conferences
16/10/14		222.79KB	Share
OCC Full Year Statutory Accounts
22/09/14		1.29MB	Share
OCC Patent Received Use of Ortho-ATI for Rotator Cuff Injuries
16/09/14	PRICE SENSITIVE	227.44KB	Share
OCC Change of Director's Interest Notice LL
16/09/14		218.04KB	Share
OCC Investor Presentation
02/09/14		2.74MB	Share
OCC Preliminary Final Report
29/08/14	PRICE SENSITIVE	268.42KB	Share
OCC Ortho-ATI Study Proves Long Term Effectiveness
25/08/14	PRICE SENSITIVE	216.59KB	Share
OCC Becoming a substantial holder MZ
22/08/14		1014.38KB	Share
OCC Becoming a substantial holder XU
22/08/14		339.32KB	Share
OCC Change of Director's Interest Notice SW
19/08/14		217.88KB	Share
OCC Becoming a substantial holder
14/08/14		140.37KB	Share
OCC Change of Director's Interest Notice SW
13/08/14		217.84KB	Share
OCC Orthocell generates first royalties from China
12/08/14	PRICE SENSITIVE	214.84KB	Share
OCC Investor Presentation
12/08/14		2.65MB	Share
OCC Becoming a substantial holder MC
12/08/14		1.1MB	Share
OCC Becoming a substantial holder QZ
12/08/14		1.37MB	Share
OCC Becoming a substantial holder from SRV
12/08/14		28.46KB	Share
OCC *Initial Director's Interest Notice 5**
12/08/14		261.06KB	Share
OCC Becoming a substantial holder PA
12/08/14		157.76KB	Share
OCC Schedule of Restricted Securities
07/08/14		28.53KB	Share
OCC Statement confirming issue of unquoted options
07/08/14		39.19KB	Share
OCC Securities Trading Policy
07/08/14		186.52KB	Share
OCC Corporate Governance Statement
07/08/14		136.88KB	Share
OCC Reviewed account for half year ending 31 December 2013
07/08/14		4.1MB	Share
OCC Audited account for year ending 30 June 2013
07/08/14		1.31MB	Share
OCC Audited account for year ending 30 June 2012
07/08/14		743.08KB	Share
OCC Audited account for year ending 30 June 2011
07/08/14		6.09MB	Share
OCC Constitution
07/08/14		484.89KB	Share
OCC Appendix 1A Information Form & Checklist
07/08/14		1.31MB	Share

REFRESH

First 3 4 5 6 7

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $1.25		Change 0.020(1.63%)		Mkt cap ! $301.1M

Open	High	Low	Value	Volume
$1.24	$1.27	$1.24	$443.2K	354.0K

Buyers (Bids)

No.	Vol.	Price($)
2	2218	$1.25

Sellers (Offers)

Price($)	Vol.	No.
$1.25	2611	3

View Market Depth

No.	Vol.	Price($)
3	8867	1.255
3	14178	1.250
3	5581	1.245
2	4662	1.240
4	66378	1.230

Price($)	Vol.	No.
1.270	24883	3
1.275	6036	3
1.280	10300	3
1.285	571	2
1.290	17575	2

Last trade - 10.14am 13/08/2025 (20 minute delay)


Last $1.25		Change 0.020 ( 2.64 %)
Open	High	Low	Volume
$1.25	$1.27	$1.23	47866
Last updated 10.34am 13/08/2025 ?

OCC (ASX) Chart

ORTHOCELL LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories